Form 4: USANA Health Sciences Director Acquires Restricted Stock Units

Frederic J. Winssinger, a director of USANA Health Sciences, acquired 4,230 restricted stock units on May 20, 2025, according to a Form 4 filing with the SEC.

Summary

• On May 20, 2025, Frederic J. Winssinger, a director of USANA Health Sciences, acquired 4,230 restricted stock units.
• Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
• The restricted stock units vest in four equal installments: 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
• Following the transaction, Winssinger directly owns 4,230 shares of USNA common stock represented by these units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to stock options, which doesn't inherently indicate positive or negative sentiment.

Positives

• The acquisition of restricted stock units by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Insider transactions are routinely monitored as indicators of management's perspective on the company's valuation and prospects within the health sciences industry.

Comparison to Industry Standards

• Comparing the vesting schedule and size of the grant to similar grants at companies like Herbalife Nutrition or Nu Skin Enterprises would provide context on whether this is a typical incentive for a director.
• Benchmarking against industry standards for director compensation packages can help determine if the grant is aligned with performance expectations and market practices.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company director.

Key Dates

Keywords

USANA Health Sciences, Form 4, restricted stock units, insider trading, beneficial ownership, Winssinger, USNA, director